FOXO1 and cholangiocarcinoma: Recently, it has emerged that FoxO1, another member of the FoxO family, impairs autophagic flux in human CCA cells, leading to oxidative stress, mitochondrial dysfunction, and apoptosis, identifying this transcription factor as a potential therapeutic target for CCA treatment [70].